Long Island Gastrointestinal Research Group — Great Neck, New York

Long Island Gastrointestinal Research Group is a clinical research site located in Great Neck, New York, United States 11023.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Long Island Gastrointestinal Research Group has participated in 21 clinical trials.

Therapeutic areas: Opioid-Induced Bowel Dysfunction, Enteric Hyperoxaluria, Diabetic Gastroparesis.

Sponsors: Sucampo Pharma Americas, LLC, Allena Pharmaceuticals, Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Long Island Gastrointestinal Research Group?

Long Island Gastrointestinal Research Group has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Long Island Gastrointestinal Research Group conducted?

Long Island Gastrointestinal Research Group has 21 clinical trials on record. Their work covers Opioid-Induced Bowel Dysfunction, Enteric Hyperoxaluria, Diabetic Gastroparesis.

Is Long Island Gastrointestinal Research Group accredited by Crixeo Health?

Yes — Long Island Gastrointestinal Research Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Long Island Gastrointestinal Research Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.